Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Condition:   Advanced Renal Cell Carcinoma Interventions:   Drug: Botensilimab;   Drug: Balstilimab;   Drug: Ipilimumab;   Drug: Nivolumab Sponsors:   Michael B. Atkins, MD;   Agenus Inc.;   Georgetown University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials